Trials / Recruiting
RecruitingNCT07032688
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 Injection at Steady State in Subjects With Type 2 Diabetes
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-3167 Injection | SHR-3167 injection. |
| DRUG | Insulin Degludec Injection | Insulin Degludec injection. |
Timeline
- Start date
- 2025-08-11
- Primary completion
- 2027-03-01
- Completion
- 2027-04-01
- First posted
- 2025-06-24
- Last updated
- 2026-04-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07032688. Inclusion in this directory is not an endorsement.